Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |